ASX [ASE Technology] 6-K: (Original Filing)
[]
[Subject : To announce the differences between the second quarter of 2019 financial statements under Taiwan-IFRSs and IFRSs To which item it meetsarticle 4 paragraph xx:47 (Form 1) Date of events:2019/8/14 Contents: 1.Date of occurrence of the event: 2019/8/14 2.Of which year/ quarter financial repo]
[Subject : To announce the differences between the second quarter of 2019 financial statements under Taiwan-IFRSs and IFRSs To which item it meetsarticle 4 paragraph xx:47 (Form 1) Date of events:2019/8/14 Contents: 1.Date of occurrence of the event: 2019/8/14 2.Of which year/ quarter financial repo]
[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]
[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]
[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]
[PRELIMINARY PROXY STATEMENT - SUBJECT TO COMPLETION - DATED AUGUST 14, 2019 [ ], 2019 To the Stockholders of Highpower International, Inc.:]
[China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results HANGZHOU, China, August 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healt]
[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]